The diverse marketed formulations of advanced nano drug carrier vehicles (and CVS) in different biomedical treatments: a complete descriptive review

Abstract

The field of pharmaceutical science and drug delivery has seen a remarkable transformation in recent years, marked by the emergence of diverse advanced approaches in the development of Novel Drug Delivery Systems (NDDs) and their associated carriers. Nanocarriers are tiny particles that can be used to deliver drugs to the body. They are typically less than 100 nanometres in diameter, which is about 1,000 times smaller than the width of a human hair. NDDs play a pivotal role in enhancing the therapeutic efficacy, safety, and patient compliance of pharmaceuticals. The research community has increasingly focused on creating novel drug delivery systems to address the limitations of conventional drug administration methods. The diversification of these approaches is notable, reflecting the interdisciplinary nature of pharmaceutical sciences. NDDs can be used to deliver drugs to specific sites in the body, control the rate of drug release, and protect drugs from degradation. Carriers play an important role in NDDs. The main highlights of the review articles in to focus on the diverse nano drug carriers including niosome, liposome, aquasome, nanoparticles (NPs) and phytosomes with their marketed available different products with their specified disease targeting.